1,2,3,4,6-penta-O-galloyl-beta-d-glucose attenuates renal cell migration, hyaluronan expression, and crystal adhesion

European Journal of Pharmacology

Volumn 606, Issue 1-3, 2009, Pages 32-37

  Lee, Jae Ho ^a,b   Yehl, Matthew ^a   Ahn, Kwang Seok ^b   Kim, Sung Hoon ^a,b   Lieske, John C ^a  

^a Mayo Clinic College of Medicine   (United States)

^b Kyung Hee University   (South Korea)

Author keywords

Calcium oxalate; Cell movement; Chinese herbal drugs; Hyaluronic acid

Indexed keywords

GLUCOSE PENTAGALLATE; HYALURONIC ACID; WHEWELLITE;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; CRYSTAL; CYTOTOXICITY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UROLITHIASIS;

ANIMALS; CALCIUM OXALATE; CELL ADHESION; CELL LINE; CELL MOVEMENT; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HYALURONIC ACID; HYDROLYZABLE TANNINS; KIDNEY; WOUND HEALING;

EID: 60949092867     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.024     Document Type: Article

References (30)

1. Almond A. Hyaluronan. Cell. Mol. Life Sci. 64 (2007) 1591-1596
2. Atmani F., Farell G., and Lieske J.C. Extract from Herniaria hirsuta coats calcium oxalate monohydrate crystals and blocks their adhesion to renal epithelial cells. J. Urol. 172 (2004) 1510-1514
3. Bhimani R.S., Troll W., Grunberger D., and Frenkel K. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res 53 (1993) 4528-4533
4. Campos A.H., and Schor N. Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis. Nephron 81 (1999) 393-397
5. Erdelyi K., Kiss A., Bakondi E., Bai P., Szabo C., Gergely P., Erdodi F., and Virag L. Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Mol. Pharmacol. 68 (2005) 895-904
6. Evan A., Lingeman J., Coe F.L., and Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 69 (2006) 1313-1318
7. Evan A.P., Coe F.L., Lingeman J.E., Shao Y., Sommer A.J., Bledsoe S.B., Anderson J.C., and Worcester E.M. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat. Rec. (Hoboken) 290 (2007) 1315-1323
8. Evan A.P., Coe F.L., Gillen D., Lingeman J.E., Bledsoe S., and Worcester E.M. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat. Rec. (Hoboken) 291 (2008) 325-334
9. Farell G., Huang E., Kim S.Y., Horstkorte R., and Lieske J.C. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals. J. Am. Soc. Nephrol. 15 (2004) 3052-3062
10. Flagg L.R. Dietary and holistic treatment of recurrent calcium oxalate kidney stones: review of literature to guide patient education. Urol. Nurs. 27 (2007) 113-122 143; quiz 123
11. Grases F., March J.G., Ramis M., and Costa-Bauz'a A. The influence of Zea mays on urinary risk factors for kidney stones in rats. Phytotherapy Res. 7 (1993) 146-149
12. Grases F., Ramis M., Costa-Bauza A., and March J.G. Effect of Herniaria hirsuta and Agropyron repens on calcium oxalate urolithiasis risk in rats. J. Ethnopharmacol. 45 (1995) 211-214
13. Hadjzadeh M.A., Khoei A., Hadjzadeh Z., and Parizady M. Ethanolic extract of Nigella sativa L seeds on ethylene glycol-induced kidney calculi in rats. Urol. J. 4 (2007) 86-90
14. Hofmann A.S., and Gross G.G. Biosynthesis of gallotannins: formation of polygalloylglucoses by enzymatic acylation of 1,2,3,4,6-penta-O-galloylglucose. Arch. Biochem. Biophys. 283 (1990) 530-532
15. Huh J.E., Lee E.O., Kim M.S., Kang K.S., Kim C.H., Cha B.C., Surh Y.J., and Kim S.H. Penta-O-galloyl-beta-d-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 26 (2005) 1436-1445
16. Jeong B.C., Kim B.S., Kim J.I., and Kim H.H. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J. Endourol. 20 (2006) 356-361
17. Ji M.S., Piao X.L., Jin Y.L., and Park R.D. Anticoagulant 1,2,3,4,6-pentagalloyl-beta-d-glucopyranose isolated from geranium (Pelargonium inquinans Ait). Arch. Pharm. Res. 28 (2005) 1037-1041
18. Kang D.G., Moon M.K., Choi D.H., Lee J.K., Kwon T.O., and Lee H.S. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-d-glucose (PGG) via a nitric oxide-cGMP pathway. Eur. J. Pharmacol. 524 (2005) 111-119
19. Khan S.R. Interactions between stone-forming calcific crystals and macromolecules. Urol. Int. 59 (1997) 59-71
20. Kumar V., Farell G., and Lieske J.C. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J. Urol. 170 (2003) 221-225
21. Lieske J.C., Leonard R., and Toback F.G. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am. J. Physiol. 268 (1995) F604-F612
22. Micali S., Grande M., Sighinolfi M.C., De Carne C., De Stefani S., and Bianchi G. Medical therapy of urolithiasis. J. Endourol. 20 (2006) 841-847
23. Oh G.S., Pae H.O., Oh H., Hong S.G., Kim I.K., Chai K.Y., Yun Y.G., Kwon T.O., and Chung H.T. In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett. 174 (2001) 17-24
24. Okubo T., Nagai F., Seto T., Satoh K., Ushiyama K., and Kano I. The inhibition of phenylhydroquinone-induced oxidative DNA cleavage by constituents of Moutan Cortex and Paeoniae Radix. Biol. Pharm. Bull. 23 (2000) 199-203
25. Park S., and Pearle M.S. Pathophysiology and management of calcium stones. Urol. Clin. North Am. 34 (2007) 323-334
26. Porena M., Guiggi P., and Micheli C. Prevention of stone disease. Urol. Int. 79 Suppl. 1 (2007) 37-46
27. Selvam R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol. Res. 30 (2002) 35-47
28. Verhulst A., Asselman M., Persy V.P., Schepers M.S.J., Helbert M.F., Verkoelen C.F., and DeBroe M.E. Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding- into a nonadherent epithelium. J. Am. Soc. Nephrol. 13 (2003) 107-115
29. Verkoelen C.F., and Verhulst A. Proposed mechanisms in renal tubular crystal retention. Kidney Int. 72 (2007) 13-18
30. Zhao W.H., Gao C.C., Ma X.F., Bai X.Y., and Zhang Y.X. The isolation of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose from Acer truncatum Bunge by high-speed counter-current chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 850 (2007) 523-527